Results of primary endoscopic Dacryocystorhinostomy surgery with and without silicon stenting in patients with epiphora
Not Applicable
- Conditions
- Primary acquired nasoLacrimal duct obstruction.Acquired stenosis of nasolacrimal ductH04.55
- Registration Number
- IRCT20200718048126N1
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Patients 18 years of age and older with persistent epiphora or recurrent ocular discharge with primary diagnosis of acquired nasolacrimal duct obstruction referred to Amir Al-Momenin hospital of Rasht
Exclusion Criteria
Previous history of nasolacrimal duct surgery, suspicion of lacrimal sac malignancy, canalicular obstruction requires membranectomy, presence of punctum and eyelid ectropion and facial nerve palsy and lid lag, history of Radiotherapy and trauma and important disease in examined side of the nose and orbit, immunodeficiencies and uncontrolled systemic disease, congenital dacryocystitis, presence of abnormal bleeding disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of symptoms; nasolacrimal duct and ostium opening in endoscopy; No dacryocystitis. Timepoint: Patients will be followed up for 12 months. The first postoperative visit will take place in the first week and then in the 1st, 3rd, 6th and 12th months. All the consequences studies are examined in the all Visits. If patients have a stent, it will be removed during the third month visit. Method of measurement: The studied variables are examined by physical examination and nasal endoscopy in the first week after surgery and then 1st, 3rd, 6th and 12th months.
- Secondary Outcome Measures
Name Time Method